Rhythm Pharmaceuticals Inc (RYTM)

04:49 AM

Corebridge Financial Inc. Has $1.52 Million Stock Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

04:49 AM

Apr 02, 2025

(RYTM) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Apr 02, 2025

Apr 01, 2025

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $69.46 Average Target Price from Analysts - Defense World

Apr 01, 2025

Mar 31, 2025

Teacher Retirement System of Texas Increases Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - The AM Reporter

Mar 31, 2025

Mar 31, 2025

When Will Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Breakeven? - simplywall.st

Mar 31, 2025

Mar 31, 2025

Teacher Retirement System of Texas Has $761,000 Stock Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

Mar 31, 2025

Mar 30, 2025

Rhythm Pharma ends RareStone licensing deal in China - MSN

Mar 30, 2025

Mar 30, 2025

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Mar 30, 2025

Mar 27, 2025

Equities Analysts Offer Predictions for RYTM Q1 Earnings - Defense World

Mar 27, 2025

Mar 26, 2025

Q2 Earnings Estimate for RYTM Issued By HC Wainwright - Defense World

Mar 26, 2025

Mar 25, 2025

Swiss National Bank Has $5.05 Million Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

Mar 25, 2025

Mar 25, 2025

Rhythm Pharmaceuticals (NASDAQ:RYTM) Given Buy Rating at HC Wainwright - Defense World

Mar 25, 2025

Mar 24, 2025

Rhythm Pharmaceuticals corporate controller sells shares for $18,655 By Investing.com - Investing.com Australia

Mar 24, 2025

Mar 24, 2025

Rhythm Pharmaceuticals corporate controller sells shares for $18,655 - Investing.com India

Mar 24, 2025

Mar 24, 2025

Analyst Expectations For Rhythm Pharmaceuticals's Future - Benzinga

Mar 24, 2025

Mar 23, 2025

Is Rhythm Pharmaceuticals (RYTM) a Worst High-Risk High-Reward Growth Stock to Buy? - MSN

Mar 23, 2025

Mar 23, 2025

(RYTM) Proactive Strategies - news.stocktradersdaily.com

Mar 23, 2025

Mar 21, 2025

Rhythm Pharma stock down as licensing deal ends (RYTM:NASDAQ) - Seeking Alpha

Mar 21, 2025

Mar 21, 2025

Victory Capital Management Inc. Reduces Stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

Mar 21, 2025

Mar 20, 2025

Rhythm Pharmaceuticals regains rights to obesity drug in China By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd. - MarketScreener

Mar 20, 2025

Mar 20, 2025

Rhythm Pharmaceuticals regains rights to obesity drug in China - Investing.com India

Mar 20, 2025

Mar 20, 2025

Rhythm Pharmaceuticals Reacquires Licensing Rights to - GlobeNewswire

Mar 20, 2025

Mar 20, 2025

Strategic Win: Rhythm Pharmaceuticals Reclaims IMCIVREE Rights in China, Strengthens Global Position - StockTitan

Mar 20, 2025

Mar 20, 2025

Rhythm Pharmaceuticals Announces Orphan Drug Designation - GlobeNewswire

Mar 20, 2025

Mar 19, 2025

Rhythm Pharmaceuticals receives orphan drug status in Japan By Investing.com - Investing.com Australia

Mar 19, 2025

Mar 19, 2025

Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted To Setmelanotide For Treatment Of Hypothalamic Obesity In Japan - Marketscreener.com

Mar 19, 2025

Mar 19, 2025

Rhythm Pharmaceuticals receives orphan drug status in Japan - Investing.com

Mar 19, 2025

Mar 19, 2025

Rhythm Pharmaceuticals Receives Orphan-Drug Designation in Japan for Obesity Treatment - MarketWatch

Mar 19, 2025

Mar 19, 2025

Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted to Setmelanotide for Treatment of Hypothalamic Obesity in Japan - The Manila Times

Mar 19, 2025

Mar 19, 2025

Breakthrough for Rare Obesity: Rhythm's Drug Wins Special Status in Japan - StockTitan

Mar 19, 2025

Mar 19, 2025

Rhythm Pharmaceuticals EVP sells shares worth $3.86 million By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Charles Schwab Investment Management Inc. Has $24.65 Million Stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

Mar 19, 2025

Mar 19, 2025

Rhythm Pharmaceuticals (NASDAQ:RYTM) Given New $66.00 Price Target at Needham & Company LLC - Defense World

Mar 19, 2025

Mar 18, 2025

Rhythm Pharmaceuticals EVP sells shares worth $3.86 million - Investing.com India

Mar 18, 2025

Mar 18, 2025

Needham raises Rhythm Pharma stock target to $66, maintains buy By Investing.com - Investing.com UK

Mar 18, 2025

Mar 18, 2025

Rhythm Pharmaceuticals and Raymond A. Wood Foundation Launch Research Collaboration on Fatigue in Craniopharyngioma Patients - Nasdaq

Mar 18, 2025

Mar 18, 2025

Rhythm Pharmaceuticals and Raymond A. Wood Foundation Announce Research Collaboration - GlobeNewswire

Mar 18, 2025

Mar 15, 2025

Bank of New York Mellon Corp Sells 680 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

Mar 15, 2025

Mar 14, 2025

Insider Sell Alert: EVP, Head of North America Jennifer Lee Sells Shares of Rhythm Pharmaceuticals Inc (RYTM) - GuruFocus.com

Mar 14, 2025

Mar 12, 2025

How To Trade (RYTM) - Stock Traders Daily

Mar 12, 2025

Mar 12, 2025

SBI Securities Co. Ltd. Invests $37,000 in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

Mar 12, 2025

Mar 12, 2025

Stifel maintains Buy on Rhythm Pharmaceuticals, $78 target By Investing.com - Investing.com Canada

Mar 12, 2025

Mar 12, 2025

Stifel maintains Buy on Rhythm Pharmaceuticals, $78 target - Investing.com India

Mar 12, 2025

Mar 10, 2025

Reviewing Wave Life Sciences (NASDAQ:WVE) & Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World

Mar 10, 2025